Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Letrozole in Platinum-Resistant Ovarian and Endometrial Cancer
NCT02188550Phase 2Unknown
- Sponsor
- Sinai Hospital of Baltimore
- Start
- Jun 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in ovarian cancer, endometrial cancer (EC), fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by Sinai Hospital of Baltimore. Status: unknown.
02
Drugs
everolimus
03
Conditions
ovarian cancerendometrial cancer (EC)fallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT02188550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188550.